News articles about Senseonics Holdings (NASDAQ:SENS) have been trending somewhat positive recently, Accern reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Senseonics Holdings earned a daily sentiment score of 0.15 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 45.1565499424578 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

SENS has been the topic of a number of analyst reports. BTIG Research reaffirmed a “buy” rating and issued a $4.50 price target on shares of Senseonics Holdings in a research note on Sunday, May 28th. Zacks Investment Research raised Senseonics Holdings from a “sell” rating to a “hold” rating in a research note on Tuesday, August 15th.

Senseonics Holdings (SENS) traded up 1.33% during trading on Friday, hitting $3.05. The stock had a trading volume of 525,227 shares. The stock’s market cap is $375.76 million. The stock has a 50 day moving average price of $3.09 and a 200-day moving average price of $3.09. Senseonics Holdings has a 12 month low of $2.15 and a 12 month high of $4.05.

Senseonics Holdings (NASDAQ:SENS) last issued its quarterly earnings results on Wednesday, August 9th. The company reported ($0.12) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.13) by $0.01. The business had revenue of $0.81 million for the quarter, compared to the consensus estimate of $0.81 million. On average, equities analysts predict that Senseonics Holdings will post ($0.54) EPS for the current year.

In related news, COO Mukul Jain sold 13,115 shares of the firm’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $3.25, for a total transaction of $42,623.75. Following the completion of the sale, the chief operating officer now directly owns 13,115 shares of the company’s stock, valued at approximately $42,623.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

TRADEMARK VIOLATION NOTICE: This piece of content was first reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark law. The original version of this piece of content can be read at

Senseonics Holdings Company Profile

Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.

Insider Buying and Selling by Quarter for Senseonics Holdings (NASDAQ:SENS)

Receive News & Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.